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Localized abscess in an organ is generally treated with
surgical drainage and, in some cases, systematic administra-
tion of appropriate antibiotics. Removal of an organ impaired
by infection is rarely performed except in critical cases. We
encountered a patient who required a penectomy for persis-
tent abscess of the corpus cavernosum due to secondary
infection with methicillin-resistant Staphylococcus aureus
(MRSA).
A 54-year-old man presented with a one-week history of
pain in the base of the penis unrelated to urination, with non-
systemic symptoms. The patient denied any recent sexually
transmitted disease, trauma, voiding symptoms, use of ure-
thral instruments, tuberculosis, and diabetes or other sys-
temic disease. He suffered from erectile dysfunction, which
had gone unattended. Physical examination revealed a pain-
ful nodule of the right and left corpus cavernosum close to
the crus of the penis and a normal prostate. Routine labora-
tory tests including urinalysis showed no abnormalities. T2-
weighted magnetic resonance imaging of the pelvis showed
localized bilateral abscess formation in the corpus caverno-sum (Figure 1). Exploration of the right base of the penile
shaft by lateral approach revealed a sterile abscess of the
cavernosum. Moreover, biopsy of the abscess wall showed
fibrous tissue but neither tubercular change nor cancerous
tissue. Although the patient’s symptoms disappeared tem-
porarily after removal of pus with a Penrose drain and
intravenous injection of a broad-spectrum antibiotic for 10
days, the wound ruptured spontaneously after three weeks
and discharged new pus, the culture of which yielded MRSA.
The drainage volume increased, and the pain in the penis
worsened daily. The patient was re-hospitalized after three
months due to gait disturbance and a fever of 38 8C, and was
given injections of vancomycin for seven days. Despite treat-
ment, his condition deteriorated, and a total penectomy and
perineal urethrostomy were performed. His condition
improved substantially, and he was discharged in good health
14 days later. The surgical specimen revealed various inflam-
matory infiltrates, granulomatous change, and cell debris in
the right and left corpus cavernosum with a few epithelioid
cells. Staining by the Ziehl—Neelsen method was negative;
however, culture of the surgical specimen forMycobacterium
was not performed.
Abscess of the corpus cavernosum is rare and can develop
after trauma,1 as a complication of cavernosography,2 as an
unusual presentation of gonorrhea,3 after intracorporeal
injections,4 or from undetermined causes,5,6 as in our case.
It can usually be managed by drainage and antibiotic ther-
apy;6,7 however, penectomy may be necessary in persistent
cases.
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The recent rise in penicillin resistance worldwide has led to
the increased use of cephalosporins, macrolides and fluor-
oquinolones as first line therapies in community-acquired
respiratory infections.1 We tested the activity of various
antimicrobial agents against clinical isolates of Streptococ-
cus pneumoniae, Haemophilus influenzae and Moraxella
catarrhalis at a tertiary hospital in Lebanon.
A total of 92 isolates (43 S. pneumoniae, 37 H. influenzae
and 12 M. catarrhalis) were recovered from unique conse-
cutive clinical specimens at the American University of Beirut
Medical Center between May 2003 and July 2004. Determina-
tion of the minimal inhibitory concentrations (MICs) of anti-
microbial agents was performed according to the E-test
manufacturer’s protocols (AB Biodisk 2001, E-test Technical
Manual, Solna, Sweden). The following reference bacterial
strains were used: S. pneumoniae (ATCC 49619) and H.
influenzae (ATCC 49247). Results of MICs were interpreted
based on Clinical and Laboratory Standards Institute (CLSI)
breakpoints.2
Most clinical specimens consisted of sputum (33%), naso-
pharynx (18%) and deep tracheal aspirates (16%). S. pneu-
moniae isolates showed uniform susceptibility to
gatifloxacin, levofloxacin and amoxicillin/clavulanate
(Table 1). Susceptibility to penicillin was very low (28%);
intermediate susceptibility and resistance to penicillin was
found in 58% and 14% of isolates, respectively. The six
penicillin-resistant isolates showed uniform resistance to
cefuroxime, azithromycin and clindamycin. S. pneumoniae
isolates recovered from blood (n = 8) exhibited better sus-
ceptibility to penicillin than non-blood isolates (n = 35) (50%
vs. 23%). H. influenzae isolates were highly susceptible
(95—100%) to all tested antimicrobial agents except ampi-
cillin to which eight b-lactamase producing isolates (22%)
were resistant. Twenty-nine H. influenzae isolates (78%)
were serotype b (Mast Diagnostic, Merseyside, UK); the
prevalence of b-lactamase production was similar among
serotype b (21%) and non-serotype b isolates (22%). M.
catarrhalis isolates were uniformly susceptible to all testedantimicrobial agents except ampicillin to which only 5% of
isolates were susceptible. b-Lactamase production was con-
firmed in 95% of isolates.
The latest data from global surveillance studies indicate
that the rates of penicillin resistant S. pneumoniae (PRSP)
vary widely by geographic location.3 Our penicillin resistance
rate of 14% compares well with previous studies from Leba-
non which showed 13% resistance in 1996 and 18% in 1999.4—6
We found that 35% of S. pneumoniae isolates were resis-
tant tomacrolides, amuch higher figure than that reported in
a previous study.4 In addition, all PRSP isolates and a large
proportion of intermediately susceptible isolates were at the
same time resistant to cefuroxime, azithromycin and clin-
damycin. It should be noted that the impact of penicillin
resistance among pneumococcal isolates on clinical outcome
remains unclear. There is evidence to suggest that b-lactams
can still be used to treat non-invasive pneumococcal infec-
tions caused by PRSP if adequate doses are administered.7 On
the other hand, b-lactams should be avoided when treating
PRSP-related meningitis and bloodstream infections.
All tested S. pneumoniae,H. influenzae andM. catarrhalis
isolates were susceptible to levofloxacin and gatifloxacin.
The incidence of fluoroquinolone resistance in the USA and
Europe is low (0—2%).3,8 Higher resistance rates have been
reported from Hong Kong (11%) as a consequence of the
spread of a single resistant clone.3 To date, there have been
no reported cases of resistance to fluoroquinolones among S.
pneumoniae in Lebanon. This is consistent with data from
other countries in the Middle East such as Saudi Arabia and
Qatar.9,10
Gatifloxacin has been shown in clinical trials to be equiva-
lent to b-lactam antibiotics in the treatment of various
respiratory infections.11,12 However, recent reports of dys-
glycemia in patients receiving gatifloxacin and the risk of
selecting for resistance during and following therapy should
be taken into consideration when selecting a therapeutic
agent for respiratory infections.13 For H. influenzae, the
high rates of susceptibility to gatifloxacin can be extrapo-
lated to other new-generation fluoroquinolones such as
moxifloxacin. Although moxifloxacin and gatifloxacin have
the same susceptibility breakpoints, CLSI instructions do not
specify extrapolation for S. pneumoniae isolates. Further
studies should be conducted to confirm moxifloxacin sus-
ceptibility.
Although fluoroquinolone resistance has not yet been
reported in Lebanon, yearly surveillance is recommended,
